Although EGFR is a prognostic marker of various advanced stage carcinomas such as breast [43], ovarian [44], prostate [45], [46] and non-small cell lung cancers [47], the role of EGFR expression and signaling in CSCs has only recently been investigated. This evidence concerns the gene EGFR and carcinoma.